Eduardo Reategui

Title: Innovations by Eduardo Reategui in Cancer Immunotherapy

Introduction

Eduardo Reategui is an accomplished inventor based in Columbus, OH. He has made significant contributions to the field of cancer immunotherapy through his innovative research and development of advanced technologies.

Latest Patents

Reategui holds a patent for a highly sensitive platform designed to characterize extracellular vesicular biomarkers for cancer immunotherapy. The patent, titled "Methods and systems for characterizing extracellular vesicular biomarkers using a biochip with gold nanoparticles," outlines a biochip that includes a glass surface, a gold film layer on the glass surface, a plurality of gold nanoparticles coupled to the gold film layer, and a plurality of biotinylated antibodies coupled to the gold nanoparticles. In some implementations, the gold film layer of the biochip is coated with polyethylene glycol (PEG). The biotinylated antibodies are specifically selected to capture distinct types of extracellular vesicles. This innovative technology allows for the characterization of PD-L1/PD-1 proteins and RNAs in extracellular vesicles, which is crucial for advancing cancer immunotherapy.

Career Highlights

Eduardo Reategui is affiliated with The Ohio State University, where he continues to engage in groundbreaking research. His work focuses on the intersection of nanotechnology and cancer treatment, aiming to improve patient outcomes through innovative solutions.

Collaborations

Reategui collaborates with Thi Hien Luong Nguyen, contributing to the advancement of research in the field of cancer immunotherapy.

Conclusion

Eduardo Reategui's innovative work in developing a biochip for cancer immunotherapy exemplifies the potential of technology to transform medical treatments. His contributions are paving the way for future advancements in the field.